SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-034509
Filing Date
2022-06-06
Accepted
2022-06-06 16:15:45
Documents
1
Period of Report
2022-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8944
  Complete submission text file 0001209191-22-034509.txt   10521
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Issuer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATHENEX, INC., 1001 MAIN STREET, SUITE 600 BUFFALO NY 14203
Business Address
Cook Timothy DeVere (Reporting) CIK: 0001902974 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38112 | Film No.: 22998239